Published in Gastroenterology on December 07, 2007
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
IgG4-related sclerosing disease. World J Gastroenterol (2008) 3.84
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol (2011) 2.51
Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol (2010) 2.25
Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol (2010) 1.95
IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70
Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology (2013) 1.58
Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol (2012) 1.55
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Aliment Pharmacol Ther (2011) 1.52
Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology (2011) 1.49
Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification. J Gastroenterol (2011) 1.49
Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis. Gastroenterology (2015) 1.45
Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver (2009) 1.43
Diagnosis of IgG4-related sclerosing cholangitis. World J Gastroenterol (2013) 1.32
Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol (2014) 1.26
IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J (2012) 1.26
IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil. J Neurol Sci (2012) 1.19
IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis (2014) 1.17
Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol (2010) 1.14
Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol (2011) 1.14
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology (2014) 1.13
Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol (2014) 1.11
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol (2010) 1.08
Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature. Pediatr Rheumatol Online J (2011) 1.04
Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J Gastroenterol (2013) 1.04
Retroperitoneal fibrosis associated with immunoglobulin G4-related disease. World J Gastroenterol (2013) 1.02
Immunology of IgG4-related disease. Clin Exp Immunol (2015) 1.00
Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol (2013) 0.98
Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol (2010) 0.96
Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) (2015) 0.96
Usefulness of Intraductal Ultrasonography in the Diagnosis of Cholangiocarcinoma and IgG4-Related Sclerosing Cholangitis. Clin Endosc (2012) 0.94
Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol (2010) 0.94
IgG4 Cholangiopathy. Int J Hepatol (2011) 0.93
Klatskin-like lesions. HPB Surg (2012) 0.93
IgG4-associated cholangitis with cholangiocarcinoma. Virchows Arch (2011) 0.93
Recent advances in autoimmune pancreatitis. Front Physiol (2012) 0.92
Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids. J Gastroenterol (2011) 0.90
Immunoglobulin g4-related sclerosing cholangitis mimicking hilar cholangiocarcinoma diagnosed with following bile duct resection: report of a case. Int Surg (2015) 0.89
Utility of pancreatography for diagnosing autoimmune pancreatitis. World J Gastroenterol (2011) 0.89
Approach to a patient with elevated serum alkaline phosphatase. Clin Liver Dis (2012) 0.88
Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol (2008) 0.88
Recent advances in the diagnosis and management of autoimmune pancreatitis: similarities and differences in Japan and Korea. Gut Liver (2013) 0.86
Immunoglobulin g4-related disease mimicking unresectable gallbladder cancer. Gut Liver (2013) 0.86
The great mimicker: IgG4-related disease. Clin Rheumatol (2013) 0.84
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort. Am J Gastroenterol (2016) 0.84
Intrathoracic Involvements of Immunoglobulin G4-Related Sclerosing Disease. Medicine (Baltimore) (2015) 0.84
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Clin Transl Gastroenterol (2015) 0.84
Clinical significance of immunoglobulin G4-associated autoimmune hepatitis. J Gastroenterol (2010) 0.84
Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol (2008) 0.84
IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis. Dig Dis Sci (2010) 0.84
Cavitating Lung Disease: A Novel Presentation of IgG4-Related Disease. Am J Case Rep (2015) 0.84
IgG4 related disease - a retrospective descriptive study highlighting Canadian experiences in diagnosis and management. BMC Gastroenterol (2013) 0.84
How to Diagnose Immunoglobulin G4-Associated Cholangitis: The Jack-of-All-Trades in the Biliary Tract. Viszeralmedizin (2015) 0.83
Current status of therapy in autoimmune liver disease. Therap Adv Gastroenterol (2009) 0.83
IgG4 related renal disease: A wolf in sheep's clothing. Indian J Nephrol (2014) 0.83
IgG4 Levels in Bile for Distinguishing IgG4-Associated Cholangiopathy from Other Biliary Disorders: A Single Blinded Pilot Study. Clin Endosc (2014) 0.83
Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis. World J Gastroenterol (2013) 0.83
IgG4-related disease: a new kid on the block or an old aquaintance? United European Gastroenterol J (2014) 0.83
Clinical analysis of 36 cases of autoimmune pancreatitis in China. PLoS One (2012) 0.83
The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol (2012) 0.82
Rituximab for the treatment of IgG4-related orbital disease: experience from five cases. Eye (Lond) (2014) 0.82
Autoimmune cholangitis mimicking a klatskin tumor: a case report. J Med Case Rep (2011) 0.82
IgG4-related sclerosing cholangitis: all we need to know. J Gastroenterol (2016) 0.82
Small bile duct involvement in IgG4-related sclerosing cholangitis: liver biopsy and cholangiography correlation. J Gastroenterol (2010) 0.82
Treatment and relapse of autoimmune pancreatitis. Gut Liver (2008) 0.82
Cystic fibrosis related liver disease--another black box in hepatology. Int J Mol Sci (2014) 0.81
Immunoglobulin G4-associated cholangitis mimicking cholangiocarcinoma treated by laparoscopic choledochectomy with intracorporeal Roux-en-Y hepaticojejunostomy. World J Surg Oncol (2014) 0.81
Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics. World J Gastroenterol (2015) 0.81
Multiple gene mutations in patients with type 2 autoimmune pancreatitis and its clinical features. Cent Eur J Immunol (2014) 0.81
Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity? World J Gastroenterol (2014) 0.80
Primary sclerosing cholangitis associated with elevated immunoglobulin-g4: a preliminary study. ISRN Gastroenterol (2012) 0.80
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies. Hepatology (2016) 0.80
Intrapancreatic common bile duct involvement of autoimmune pancreatitis: is it really IgG4-associated cholangitis? Gastroenterology (2008) 0.79
Treatment of autoimmune pancreatitis with the anecdotes of the first report. Int J Rheumatol (2012) 0.79
Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma. Gut Liver (2013) 0.79
Progressive multi-organ expression of immunoglobulin G4-related disease: A case report. World J Hepatol (2013) 0.79
Development of a scoring system for differentiating IgG4-related sclerosing cholangitis from primary sclerosing cholangitis. J Gastroenterol (2016) 0.79
Immunoglobulin g4-associated cholangitis can mimic cholangiocarcinoma on radiologic and cholangioscopic findings. Gastroenterol Hepatol (N Y) (2013) 0.79
Cholangiocarcinoma with respect to IgG4 Reaction. Int J Hepatol (2014) 0.79
IgG4-related hepatobiliary disease: an overview. Nat Rev Gastroenterol Hepatol (2016) 0.78
IgG4-related Disease: 2013 Update. Curr Treat Options Cardiovasc Med (2013) 0.78
Immunoglobulin G4-related disease mimicking asthma. Can Respir J (2013) 0.78
Comparison study of immunohistochemical staining for the diagnosis of type 1 autoimmune pancreatitis. J Gastroenterol (2014) 0.78
Usefulness of steroid administration for diagnosis of IgG4-related sclerosing cholangitis. Int Surg (2013) 0.78
Mycophenolate mofetil for maintenance of remission in steroid-dependent autoimmune pancreatitis. World J Gastroenterol (2012) 0.78
Recognition of other organ involvement might assist in the differential diagnosis of IgG4-associated sclerosing cholangitis without apparent pancreatic involvement: report of two cases. Surg Today (2012) 0.78
Diagnostic Dilemma in a Patient with Jaundice: How to Differentiate between Autoimmune Pancreatitis, Primary Sclerosing Cholangitis and Pancreas Carcinoma. Case Rep Gastroenterol (2012) 0.78
Relapse of IgG4-related sclerosing cholangitis after steroid therapy: image findings and risk factors. Eur Radiol (2014) 0.78
Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective. J Clin Transl Hepatol (2014) 0.77
Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study. PLoS One (2015) 0.77
IgG4-Associated Cholangitis Can Mimic Hilar Cholangiocarcinoma. Gut Liver (2015) 0.77
First case of IgG4-related sclerosing cholangitis associated with autoimmune hemolytic anemia. World J Gastroenterol (2014) 0.77
Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis. World J Gastroenterol (2012) 0.77
Immunoglobulin G4-related pancreatic and biliary diseases. Can J Gastroenterol (2013) 0.77
Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review. Medicine (Baltimore) (2015) 0.76
Sclerosing cholangitis associated with retroperitoneal fibrosis: a case of multisystem fibroinflammatory disorder. Hepatol Int (2010) 0.76
Therapeutic approach to IgG4-related disease: A systematic review. Medicine (Baltimore) (2016) 0.76
In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. Dig Dis Sci (2011) 0.76
The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73
Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut (2012) 10.56
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol (2013) 5.96
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc (2007) 3.59
Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol (2003) 3.36
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol (2009) 3.26
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology (2004) 3.25
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24
Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst (2003) 3.19
USP10 regulates p53 localization and stability by deubiquitinating p53. Cell (2010) 3.17
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol (2008) 3.15
Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol (2007) 3.14
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. Gastroenterology (2006) 2.87
Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol (2007) 2.82
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible? Ann Surg (2008) 2.66
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl (2015) 2.63
EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol (2009) 2.55
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49
Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol (2005) 2.46
The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology (2011) 2.42
AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. Carcinogenesis (2002) 2.41
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst (2010) 2.38
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35
Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg (2007) 2.35
Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol (2009) 2.35
ASGE Technology Status Evaluation Report: wireless capsule endoscopy. Gastrointest Endosc (2006) 2.30
Cellular changes in diabetic and idiopathic gastroparesis. Gastroenterology (2011) 2.30
Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). Gastrointest Endosc (2011) 2.30
Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointest Endosc (2008) 2.30
Endoscopic retrograde pancreatography criteria to diagnose autoimmune pancreatitis: an international multicentre study. Gut (2010) 2.29
Membranous glomerulonephritis is a manifestation of IgG4-related disease. Kidney Int (2012) 2.28